Akso Health Group annual return on equity
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Akso Health Group Return on Equity (ROE) Growth & History (AHG)
Akso Health Group's return on equity was −9.83% for fiscal 2026.
View full Akso Health Group company overviewAkso Health Group annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −9.83% | +70.16 pp |
| 2025 | 2025-03-31 | −79.99% | −67.13 pp |
| 2024 | 2024-03-31 | −12.86% | +0.09 pp |
| 2023 | 2023-03-31 | −12.95% | +101.09 pp |
| 2022 | 2022-03-31 | −114.03% | −7.48 pp |
| 2021 | 2021-03-31 | −106.55% | −25.00 pp |
| 2020 | 2020-03-31 | −81.55% | −85.71 pp |
| 2019 | 2019-03-31 | 4.15% | −75.93 pp |
| 2018 | 2018-03-31 | 80.08% | +34.39 pp |
| 2017 | 2017-03-31 | 45.69% | — |
Akso Health Group return on equity trends
Over the last five fiscal years, Akso Health Group's return on equity increased from −106.55% to −9.83%, a change of +96.72 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Akso Health Group source filings ↗